Pyxis Oncology, Inc.

PYXS · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$19,473$9,664$179,293$274,735
Short-Term Investments$107,458$109,634$0$0
Receivables$0$21$598$0
Inventory$0$0$0$0
Other Curr. Assets$5,509$5,285$6,721$3,938
Total Curr. Assets$132,440$124,604$186,612$278,673
Property Plant & Equip (Net)$22,141$24,814$24,767$1,239
Goodwill$0$0$0$0
Intangibles$2,600$24,308$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$109
Total NC Assets$24,741$49,122$24,767$1,348
Other Assets$0$0$0$0
Total Assets$157,181$173,726$211,379$280,021
Liabilities
Payables$4,859$3,896$7,097$11,951
Short-Term Debt$1,450$1,232$0$165
Tax Payable$0$0$0$0
Deferred Revenue$0$7,660$0$0
Other Curr. Liab.$11,371$12,971$24,537$6,592
Total Curr. Liab.$17,680$25,759$31,634$18,708
LT Debt$18,750$20,099$18,921$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$2,164$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$18,750$22,263$18,921$0
Other Liabilities$0$0$0$0
Cap. Leases$20,200$21,331$18,921$165
Total Liabilities$36,430$48,022$50,555$18,708
Equity
Pref Stock$0$0$0$0
Common Stock$60$45$34$32
Retained Earnings-$363,556-$286,225-$212,435-$91,718
AOCI$170$63$0$0
Other Equity$484,077$411,821$373,225$352,999
Total Equity$120,751$125,704$160,824$261,313
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$157,181$173,726$211,379$280,021
Net Debt$727$11,667-$160,372-$274,570
Pyxis Oncology, Inc. (PYXS) Financial Statements & Key Stats | AlphaPilot